ProPhase Labs, Inc. (PRPH) Ownership
PRPH ownership summary
as of October 21, 2026- Institutions
- 0.0% of shares outstanding
- Insiders
- 7.61% of shares outstanding
- Shares outstanding
- 15.6M
- Float
- 15.3M shares available to trade
- Short interest
- 3.38% 300K shares short
- Days to cover
- 0.11 short interest up 114.7% vs prior month
- Institutions 0.03%
- Insiders 7.61%
- Other investors 92.36%
PRPH top institutional holders
14 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | CoreCap Advisors, LLC | <0.01% | 10 | $0 | — | June 30, 2026 |
| 2 | BlackRock Inc | 0.00% | — | — | −126 (−100.0%) | March 31, 2026 |
| 3 | Jane Street Group LLC | 0.00% | — | — | −21,952 (−100.0%) | March 31, 2026 |
| 4 | Wells Fargo & Co | 0.00% | — | — | −23 (−100.0%) | March 31, 2026 |
| 5 | Tower Research Capital LLC | 0.00% | — | — | −163 (−100.0%) | March 31, 2026 |
| 6 | HighTower Advisors, LLC | 0.00% | — | — | −18,839 (−100.0%) | March 31, 2026 |
| 7 | SIMPLEX TRADING, LLC | 0.00% | — | — | −7,431 (−100.0%) | March 31, 2026 |
| 8 | UBS Group AG | 0.00% | — | — | −3,056 (−100.0%) | March 31, 2026 |
| 9 | Morgan Stanley - Brokerage Accounts | 0.00% | — | — | −919 (−100.0%) | March 31, 2026 |
| 10 | Geode Capital Management, LLC | 0.00% | — | — | −16,262 (−100.0%) | March 31, 2026 |
| 11 | StoneX Group Inc | 0.00% | — | — | −20,000 (−100.0%) | March 31, 2026 |
| 12 | JPMorgan Chase & Co | 0.00% | — | — | −177 (−100.0%) | March 31, 2026 |
| 13 | SBI Securities Co Ltd | 0.00% | — | — | −50 (−100.0%) | March 31, 2026 |
| 14 | Bank of America Corp | 0.00% | — | — | −114 (−100.0%) | March 31, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 14, 0 holders added 0 shares and 13 cut 89K.
PRPH top mutual fund and ETF holders
2 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | Belfund SICAV Belinvest Equity A USD Acc | 0.03% | 5,000 | $45 | — | July 31, 2026 |
| 2 | State St US Ttl Mkt Idx NL Cl A | 0.00% | 1 | $0 | +1 (0.0%) | February 28, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
PRPH insider transactions
latest 1| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2022-03-10 | Jason Michael Barr | Buy | $6.48 | 750 | $4,860 |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
PRPH shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns PRPH
Institutional investors own 0.0% of ProPhase Labs's shares and insiders 7.61%. The largest holder is CoreCap Advisors, LLC with <0.01% of the shares (10), as of June 30, 2026. Among the top 14 institutions, 0 added shares and 13 reduced their stake in the latest filings. Short interest is 3.38% of the float, or 0.11 days of average trading volume. The share count rose 468.5% since 2014.
Related: PRPH analyst forecast, PRPH key metrics. See the PRPH stock overview for the latest quote and news.
PRPH ownership FAQ
Who owns the most ProPhase Labs stock?
The largest shareholders of ProPhase Labs are CoreCap Advisors, LLC (<0.01%), BlackRock Inc (0.00%), Jane Street Group LLC (0.00%), Wells Fargo & Co (0.00%), Tower Research Capital LLC (0.00%).
What percentage of ProPhase Labs is owned by institutions?
Institutions hold 0.0% of ProPhase Labs's shares outstanding; insiders hold 7.61%.
Which funds own ProPhase Labs?
The largest fund holders of ProPhase Labs are Belfund SICAV Belinvest Equity A USD Acc (0.03%), State St US Ttl Mkt Idx NL Cl A (0.00%).
What is ProPhase Labs's short interest?
300K shares of ProPhase Labs were sold short, 3.38% of the float; at the average daily volume it would take 0.11 days to cover.
Are insiders buying or selling ProPhase Labs?
Of the latest 1 reported insider transactions in ProPhase Labs (since March 10, 2022), 1 were purchases and 0 were sales.
How many shares of ProPhase Labs are outstanding?
ProPhase Labs has 15.6M shares outstanding, of which 15.3M are in the public float.